GSK N32, Udmurt Republic

Economic indicators

Net profit (RAS) of GSK N32 made up 0 RUB over 2018 compared to 35.00 thousand RUB over 2017, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 290.00 thousand RUB in 2017; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 245.00 thousand RUB; sales profit made up 0 RUB compared to 45.00 thousand RUB.

Net profit (RAS) of GSK N32 grew over 2017 by 9.38% to 35.00 thousand RUB from 32.00 thousand RUB over 2016, the company informed.

Revenue decreased in the accounting period by 17.14% to 290.00 thousand RUB from 350.00 thousand RUB in 2016; cost of goods sold decreased by 19.14% to 245.00 thousand RUB from 303.00 thousand RUB; sales profit fell by 4.26% to 45.00 thousand RUB from 47.00 thousand RUB.

Net profit (RAS) of GSK N32 dropped in 2016 3.03 times to 32.00 thousand RUB from 97.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 16.47% to 350.00 thousand RUB from 419.00 thousand RUB in 2015; cost of goods sold grew by 7.83% to 303.00 thousand RUB from 281.00 thousand RUB; sales profit fell 2.94 times to 47.00 thousand RUB from 138.00 thousand RUB.

Net profit (RAS) of GSK N32 grew over 2014 83.00 times to 83.00 thousand RUB from 1.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period 6.41 times to 378.00 thousand RUB from 59.00 thousand RUB over 2013; cost of goods sold grew 4.76 times to 257.00 thousand RUB from 54.00 thousand RUB; sales profit went up 24.20 times to 121.00 thousand RUB from 5.00 thousand RUB.

Companies in the region

• OGNEUPOR
• Sadovodcheskoe nekommercheskoe tovarischestvo N15
• DNT " STEPANOVO"
• KAUTS
• KFKH SKOBELEVA G A